Petauri PACT Executive Briefings - 3-Minute Market Insights
Welcome to the Petauri PACT Executive Briefing, where in 3-minutes we highlight healthcare’s critical market access issues, policies, challenges, or trends. This resource offers condensed, 3-minute episodes of market insights.
Our passion is on achieving the Quintuple Aim of enhancing patient experience, improving population health, reducing costs, improving the work life of health care providers and staff., and enhancing health equity in all aspects of care delivery.
I’m Dr. Warren Smedley, thank you for joining us.
Petauri PACT Executive Briefings - 3-Minute Market Insights
Part 1 - Dr. Marty Heslin talks about the "New Normal" for cancer care
Part 1 - Dr. Marty Heslin talks about the New Normal for cancer care
Dr. Marty Heslin is the new Cancer Center Director for the University of South Alabama Mitchell Cancer Institute in Mobile, Alabama. He is a Surgical Oncologist, and has spent the last 25 years at the University of Alabama at Birmingham Health System, where he most recently served as the Chief of the Medical Staff, and Executive Vice Chair of Surgery.
In this episode we take a look at how the COVID-19 pandemic has changed the delivery of cancer care. 2020 has been a transformative year in many different ways… not all bad… even amid the challenges there have been some tremendously positive innovations and changes that will help us improve patient care for the future. We are all scrambling to understand what the “New Normal” might look like.
In PART 1 of our interview, Dr. Heslin shares his thoughts on how the delivery of cancer care was impacted by the challenges we all faced in 2020. He speaks at length about how patients, hospitals, physicians, and clinical teams reacted to the pandemic and have demonstrated incredible resilience and fortitude throughout this last year. He also shares his findings of what he refers to as a “market research tour” of the cancer centers and hospitals within his new service area, to hear directly from these key stakeholders, what is most important them in the delivery of cancer care and what they need from a clinical partner like the Mitchell Cancer Institute.